While prophylactic or therapeutic vaccines for Hp have been investigated, no vaccine has been developed yet, probably because of high Hp genetic variability together with the fact that the infection downregulates the host’s immune response which highlights the importance of selecting Hp antigens and adjuvants capable of triggering a strong host immune reaction [24,25]. Here, HP is linked to infection.